Indication protocol
Head and neck cancer
Endpoint
Source ∆NTCP Level of
evidence
Moderate-to severe
xerostomia (patient-rated
EORTC QLQ-HN35)
Beetz 2012 ≥ 10% Level 3
Dysphagia grade ≥ II (CTCAE)
Christianen
2012
≥ 10% Level 3
Tube feeding dependence
Wopken 2014 ≥ 5% Level 3
External validation in new dataset from UMCG.
Analysis performed by independent party: The Health Innovation
Center (THINC)